Wordt geladen...
盐酸埃克替尼治疗晚期复发非小细胞肺癌的临床疗效
BACKGROUND AND OBJECTIVE: Icotinib hydrochloride is the third single target EGFR-TKI used in clinical treatment of advanced non-small cell lung cancer (NSCLC). Clinical research reports on its efficacy and survival in patients with Recurrent Advanced NSCLC are still little.The aim of this study is t...
Bewaard in:
| Gepubliceerd in: | Zhongguo Fei Ai Za Zhi |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
中国肺癌杂志编辑部
2013
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000608/ https://ncbi.nlm.nih.gov/pubmed/23676980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2013.05.05 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|